Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)
6.45
-0.14 (-2.12%)
Aug 4, 2026, 3:04 PM CST
SHE:002566 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 659.66 | 640.17 | 668.47 | 853.66 | 830.04 | 877.93 |
Revenue Growth | 5.17% | -4.23% | -21.69% | 2.85% | -5.46% | 4.19% |
Gross Profit Gross Profit Growth | 484.43 | 469.69 | 494.34 | 628.87 | 614.6 | 656.71 |
Operating Income Operating Income Growth | 13.94 | 22.16 | 56.92 | 106.86 | 88.73 | 113.97 |
Net Income Net Income Growth | 33.28 | 29 | 52.09 | 94.73 | 83.1 | 96.02 |
Earnings Per Share EPS Growth | 0.10 | 0.09 | 0.16 | 0.29 | 0.25 | 0.29 |
EPS Growth | -22.45% | -44.35% | -45.00% | 13.98% | -13.44% | 19.93% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Pharmaceutical Industry Pharmaceutical Industry Growth | 514.15 |
Health Food Industry Health Food Industry Growth | 66.77 |
Cosmetics Industry Cosmetics Industry Growth | 42.52 |
Others Others Growth | 16.74 |
Total Total Growth | 640.17 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 634.94 | 571.13 | 531.15 | 590.72 | 403.11 | 319.94 |
Total Debt Total Debt Growth | 482.42 | 445.97 | 449.59 | 476.8 | 443.55 | 415.18 |
Net Cash (Debt) Net Cash Growth | 152.52 | 125.16 | 81.56 | 113.92 | -40.44 | -95.24 |
Net Cash Growth | 66.78% | 53.45% | -28.40% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.46 | 0.38 | 0.25 | 0.34 | -0.12 | -0.29 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 108.3 | 98.74 | 58.94 | 209.13 | 145.86 | 215.1 |
Capital Expenditures CapEx Growth | -7.41 | -13.64 | -15.94 | -35.77 | -41.36 | -107.07 |
Free Cash Flow Free Cash Flow Growth | 100.89 | 85.1 | 43 | 173.36 | 104.49 | 108.04 |
Free Cash Flow Growth | 264.38% | 97.89% | -75.19% | 65.91% | -3.28% | -15.32% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 73.44% | 73.37% | 73.95% | 73.67% | 74.05% | 74.80% |
Operating Margin | 2.11% | 3.46% | 8.52% | 12.52% | 10.69% | 12.98% |
Pretax Margin | 5.25% | 4.70% | 8.91% | 13.09% | 12.20% | 14.05% |
Profit Margin | 5.04% | 4.53% | 7.79% | 11.10% | 10.01% | 10.94% |
FCF Margin | 15.29% | 13.29% | 6.43% | 20.31% | 12.59% | 12.31% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.080 | 0.080 | 0.100 | 0.150 | 0.050 | 0.030 |
Dividend Per Share Growth | -20.00% | -20.00% | -33.33% | 200.00% | 66.67% | 0% |
Dividend Yield | 1.21% | 1.06% | 1.50% | 1.76% | 0.65% | 0.35% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 64.13 | 87.08 | 43.33 | 31.13 | 32.26 | 31.16 |
Forward PE | - | 49.09 | 49.09 | 49.09 | 49.09 | 49.09 |
P/FCF Ratio | 21.16 | 29.67 | 52.49 | 17.01 | 25.66 | 27.69 |
PS Ratio | 3.24 | 3.94 | 3.38 | 3.45 | 3.23 | 3.41 |